The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / My Michael Moore Moment

My Michael Moore Moment

January 1, 2008 • By David A. Fox, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
David A. Fox, MD

In his recent movie, “Sicko,” the controversial director Michael Moore turned his attention to healthcare, specifically the difficulties in access to care faced by many Americans. I have reservations about Michael Moore’s tendency to overshoot his target and suspect that some parts of his documentaries are too contrived to be taken at face value. Nevertheless, this time he has definitely picked a topic of interest to ACR members, and indeed all healthcare professionals. The striking number of physicians in the theater when I saw “Sicko” supports that conclusion.

You Might Also Like
  • Dr. Michael Weinblatt Discusses Current & Future RA Therapies
  • A Day in the Life of Michael J. Maricic, MD
  • Expert Q&A: Dr. Michael Lockshin on APS
Explore This Issue
January 2008
Also By This Author
  • Rheumatology’s Architect

As ACR president, I am made aware of the concerns of ACR members through the numerous e-mails that stream in to our staff, the ACR list serve, and me personally, in addition to phone calls, letters, and encounters with colleagues in professional settings. On many topics—such as our educational meetings, our journals, and the Research and Education Foundation—the messages from ACR members are overwhelmingly positive and enthusiastic.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

However, there is also palpable concern—and occasionally outright anger—about many aspects of the environment in which we care for our patients. Arguably, one could link many of our greatest challenges under the theme of “access to care,” and if I were a film director in the genre of Michael Moore, I would already have enough material to create my own documentary: “Sicko Rheum.”

It’s easy to list numerous access-to-care issues that have become areas of focus for our ACR staff—especially those who work with the Committee on Rheumatologic Care (CORC) and the Government Affairs Committee (GAC)—and for the CORC, GAC, and ACR Regional Advisory Council volunteers. These include absurd cuts to bone densitometry reimbursement, arbitrary and cynical denial of coverage by payers across the country for everything from anti-cyclic citrullinated peptide tests to medications to occupational or physical therapy, and the shortage of rheumatologists. And once more (when this column was written), we are facing the 500-pound gorilla of an impending 10% cut in Medicare payments that, if implemented, would threaten access to care for a large segment of the population and the viability of many rheumatology practices.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Stranger than Fiction

My personal Michael Moore moment occurred this past fall while rounding as attending physician on our rheumatology consult service. The case of “Mr. Wolverine” was especially interesting—high fevers, inflamed joints, occasional rashes, leukocytosis, and prominent elevation of acute phase reactants—the diagnosis was adult-onset Still’s disease. Our understanding of Still’s disease as an autoinflammatory, cytokine-driven disorder has advanced dramatically in recent years, thanks to brilliant research by ACR members such as Virginia Pascual, MD, of Baylor Institute for Immunology Research (Texas), and her colleagues, who have convincingly implicated interleukin 1 as a key mediator and therapeutic target in Still’s. While treatment approaches are evolving and several choices are reasonable in such a patient, use of the interleukin-1 receptor antagonist is emerging as a compelling option, notwithstanding the lack of definitive controlled trials which are very difficult to accomplish in rare conditions.

Pages: 1 2 3 | Single Page

Filed Under: President's Perspective, Professional Topics Tagged With: AC&R, access, ACR Research and Education Foundation, Clinical Rheumatology, Diagnostic Criteria, FDA, Healthcare, Professionalism, TreatmentIssue: January 2008

You Might Also Like:
  • Dr. Michael Weinblatt Discusses Current & Future RA Therapies
  • A Day in the Life of Michael J. Maricic, MD
  • Expert Q&A: Dr. Michael Lockshin on APS
  • Rheumatologist, Cyclist Michael Weinblatt, MD, Tours America on Two Wheels

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)